Directory · ONC Oncology · Immunotherapy

ONC · Immunotherapy · modeled

Nivolumab (Opdivo) dose

Hospital buy vs billed (illustrative WAC/GPO/340B blend) Specialty distributor / 340B

What the hospital pays (acquisition)$9,800
Cash$12,800
Medicaid$9,000
Medicare$10,500
Insured$15,000
Medicaid
$9,000
Medicare
$10,500
Cash
$12,800
Insured
$15,000

Insured path is $2,200 (17%) above cash. Hospital buy $9,800 vs insured $15,000.

Payers: modeled — see evidence.